CYP7A1 and metabolic dysfunction-associated steatohepatitis: The suggested metabolic role of Cyp7a1 is partially supported by an earlier report in which overexpression of Cyp7a1 reversed strong NASH phenotypes observed in MCD diet-challenged Cyp7a1−/− mice (48).